P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB. (23rd June 2022) - Macaron, W.; Jabbour, E.; Konopleva, M.; Ravandi, F.; Jain, N.; Issa, G.; Kadia, T.; Sasaki, K.; Kebriaei, P.; Yilmaz, M.; Thompson, P.; Takahashi, K.; et al.